Clinical Trial Update: An Exploratory Study of Golidocitinib in Adult Patients With ITP [Phase 1, Phase 2]

View source ↗

Summary

An exploratory, early-phase clinical trial of golidocitinib for immune thrombocytopenia is planned and currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Golidocitinib (golidocitinib)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia (ITP) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING